AUS
NZ
UK
CA
USA
IND
Vysarn Limited (ASX:VYS) has revealed plans to place 12,142,857 ordinary fully paid shares worth approximately AUD $12.75 million as upfront consideration for acquiring 100% of Technologies International Group Pty Ltd, trading as WellTech. The shares are set for issuance on 30 September 2026 and will be subject to a 12-month voluntary escrow period. This placement utilizes Vysarn's 15% placement capacity under ASX Listing Rule 7.1, eliminating the need for separate shareholder approval.
Key Highlights
- Vysarn Limited (VYS) to issue 12,142,857 ordinary fully paid shares valued at about AUD $12.75 million.
- Share issuance forms part of upfront consideration for acquiring 100% of Technologies International Group Pty Ltd (WellTech).
- Shares proposed to be issued on 30 September 2026, with a 12-month voluntary escrow applied.
- Placement falls within Vysarn's 15% capacity under ASX Listing Rule 7.1, requiring no shareholder approval.
- New shares will rank equally with existing ordinary shares from the issue date.
Vysarn's Strategic Share Issuance to Fund WellTech Acquisition
Vysarn Limited has officially notified the ASX of its intention to issue 12,142,857 ordinary fully paid shares as part of the upfront consideration for acquiring full ownership of Technologies International Group Pty Ltd, trading as WellTech. Lodged on 28 July 2026, the update details the capital raise mechanics and timeline, marking a significant corporate development for the ASX-listed company. The share placement is valued at approximately AUD $12.75 million.
This equity-based consideration reflects Vysarn's strategic approach to financing the WellTech acquisition, preserving cash resources and avoiding debt by offering shares to the sellers. This equity structure aligns incentives between Vysarn and WellTech's sellers, a common practice in mergers and acquisitions.
Utilizing ASX Listing Rule 7.1 Placement Capacity
The proposed 12,142,857 shares fall within Vysarn's 15% placement capacity under ASX Listing Rule 7.1, which permits listed entities to issue up to 15% of their ordinary shares without shareholder approval, subject to conditions. Since the placement does not exceed this limit, no additional shareholder consent is required.
Vysarn confirmed that the shares will not be issued under the additional 10% capacity of ASX Listing Rule 7.1A, and no security holder approval was sought. This streamlined process facilitates efficient acquisition financing. The shares are an existing class of ordinary fully paid shares already quoted on the ASX under the code VYS.
12-Month Voluntary Escrow to Secure Seller Commitment
All shares issued as part of the WellTech acquisition consideration will be subject to a 12-month voluntary escrow, preventing their sale within the first year post-issuance. This standard M&A provision ensures sellers remain invested in the combined entity and helps stabilize the share price by avoiding large secondary market sales immediately after issuance.
The escrow safeguards existing shareholders by maintaining sellers' meaningful stakes during the critical integration phase. Vysarn has arrangements ensuring compliance with sections 707(3) and 1012C(6) of the Corporations Act, preventing any breach of Australian securities laws regarding secondary sales.
Share Ranking and Structure Post-Issuance
The 12,142,857 new shares will rank equally with all existing ordinary shares from their issue date, carrying identical voting, dividend, and liquidation rights. These shares are not classified as restricted securities under ASX Listing Rules beyond the 12-month escrow.
No attaching securities such as options or performance rights are involved. New shareholders will receive ordinary shares outright with full participation rights from 30 September 2026. Vysarn confirmed this issuance will not alter its dividend or distribution policy.
Scheduled Issue Date and Transaction Timeline
The shares are planned to be issued on 30 September 2026, coinciding with the anticipated completion and settlement of the WellTech acquisition. This date marks when shares will be formally recorded on Vysarn's register.
Specific milestone dates such as regulatory approvals or due diligence completion have not been disclosed. Investors should monitor further announcements regarding acquisition progress and conditions precedent to the share issuance.
Transaction Costs and Administration Details
Shares will be issued through Vysarn's share registry, incurring applicable ASX share issue fees, though specific costs were not disclosed. No lead manager, broker, or underwriter has been appointed, indicating a direct transaction between Vysarn and WellTech's sellers.
This direct negotiation approach reduces costs and streamlines the process, allowing prompt implementation once all conditions are met.
Context and Strategic Importance of WellTech Acquisition
The share issuance announcement references the acquisition of 100% of Technologies International Group Pty Ltd (WellTech) as the core transaction. For detailed strategic rationale, operational insights, financial data, and broader context, investors are directed to Vysarn's separate company update dated 28 July 2026.
The acquisition represents a major corporate event for Vysarn, with upfront consideration valued at approximately AUD $12.75 million. The 12-month escrow aligns sellers' interests with the combined entity's success post-acquisition.
Regulatory Compliance and Secondary Sale Restrictions
Vysarn confirmed that any resale of the issued shares within 12 months will comply with secondary sale provisions under sections 707(3) and 1012C(6) of the Corporations Act. Contractual arrangements ensure no breach of Australian securities laws occurs, providing regulatory assurance to Vysarn and its shareholders.
Next Steps and Shareholder Considerations
The share issuance is expected to proceed on 30 September 2026, contingent on completion of the WellTech acquisition. Investors should watch for confirmation of acquisition completion and share issuance. Upon registration, shares will become tradable subject to the escrow restrictions.
Shareholders should also monitor integration updates post-acquisition. The escrow period ends on 30 September 2027, when sellers’ shares will become freely tradable, potentially impacting ownership structure and market dynamics.
